ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,589.53
      -0.79%
      US Tech 100
      19,845.60
      -1.36%
      Dow Jones
      39,812.15
      0.23%
      Brent Oil
      85.095
      0.05%
      Bitcoin
      57,666.14
      -0.15%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      05/02/20224:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/02/20224:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/29/20228:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 5, 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/09/20228:10AMTipRanksLexicon Pharmaceuticals (LXRX) Gets a Hold Rating from J.P. MorganNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/08/20226:13AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/07/20228:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/04/20228:00AMGlobeNewswire Inc.Lexicon Welcomes New Guidelines for the Management of Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/02/202212:15PMGlobeNewswire Inc.Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology's 71st Annual Scientific Session (ACC.22)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/21/20228:01AMGlobeNewswire Inc.New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/17/20224:14PMGlobeNewswire Inc.Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of SotagliflozinNASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/11/20225:16PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      03/10/20225:24PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20227:13AMDow Jones NewsLexicon Pharma Shares Fall Premarket on Withdrawn FDA ApplicationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:01AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Clinical UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/28/20226:00AMGlobeNewswire Inc.Lexicon Voluntarily Withdraws Sotagliflozin New Drug Application and Plans Prompt Resubmission Targeted Early Q2 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/25/20229:03PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on February 28, 2022NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20226:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/14/20226:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/11/20225:41PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/09/20229:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX

      Your Recent History

      BIT
      P21J26
      NLBNPIT21J26 20240918 1600
      Delayed Upgrade Clock